Pharmamarketeer

FDA approves artificial pancreas developed by the University of Virginia

Artificial pancreas

The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology.

The University says that the artificial pancreas system, called Control-IQ and manufactured by Tandem Diabetes Care, tracks blood glucose levels with a continuous glucose monitor (Dexcom G6 CGM) and automatically delivers the hormone insulin as needed.

Using this, means that pateints do not have to test their blood sugar levels multiple times a day by fingerstick, or deliver insulin by multiple daily injections.

read more

Advertentie(s)
Geen nieuws missen?
Volg de duizenden farma professionals die Pharmamarkteer.nl via e-mail lezen

Uw inschrijving is gelukt.
Bedankt!
Naar Pharmamarkteer.nl